Abstract:The ability of natural killer (NK) cells to recognize and lyse activated T cells in vitro may allow these cells to participate in regulating adaptive immune response through inhibition of clonal expansion of antigen-activated T cells. This interaction may be tightly constrained by an interaction between inhibitory NKG2A receptors on NK cells and Qa-1-Qdm ligands on activated T cells (Qa-1-NKG2A interaction). We tested the hypothesis that Qa-1-NKG2A interaction protects activated T cells from NK lysis and is essential for clonal expansion and development of immunologic memory. We found that Qa-1-deficient CD4 cells fail to undergo antigen-induced or homeostatic expansion and develop autoimmune EAE disease due to increased susceptibility to NK cells lysis. Re-expression of Qa-1-Qdm on autoreactive CD4 cells rescues expansion of self-reactive T cell clones. These findings were confirmed using Qa-1 knock-in mice which express an amino acid exchange mutation (R72A) that eliminates Qa-1 binding to NKG2A but spares binding to the TCR. Dissection of the NK cell population revealed that the NKG2A+ but not NKG2A– subset of NK cells mediate lysis of Qa-1-deficient CD4 cells. Blockage of the Qa-1-NKG2A interaction that constrains NK lysis of activated T cells resulted in potent NK-dependent elimination of activated autoreactive T cells and amelioration of autoimmune EAE. These findings extend the functional reach of the NK system to include regulation of adaptive T cell responses and demonstrate that antibody-mediated blockade of NKG2A-Qdm interactions as a new clinical approach to eliminate antigen-activated T cells in the context of autoimmune disease or transplantation.

Definition of a Qa-1-Qdm-dependent Interaction Between NK Cells and Activated T Cells That Inhibits Expansion and Memory Development of Pathogenic T Cells (88.31)